glp-1 and gip dual agonist GIPR/GLP-1R therapies for diabetes weight loss—chemistry, physiology, and clinical applications Fair Allocation of GLP-1 and
Description
doi:10.1016/j.gene.2016.05.018 165
10.1056/NEJMoa2401943
[DOI] [PubMed] [Google Scholar] 94.Abbass NJ, et al
For 40+ years, my work and that of others supported the view that addiction is a disorder of maladaptive dopaminergic learning
Movement traces and quantification of locomotor activity (velocity and distance travelled) were obtained using Noldus EthoVision XT software (Noldus)
These findings underscore the multifaceted nature of GLP-1 receptor agonists in cardiovascular risk reduction and have profound implications for the treatment of different profiles of T2D patients
